Zoom Technology shares suspended

Technically Speaking, the Dow Just Rocketed Out of a Bear Market

(Bloomberg) -- As ridiculous as it sounds, the Dow Jones Industrial Average just climbed out of the bear market it entered two weeks ago.It’s a development that speaks to the tenuousness of market conventions in times of extreme volatility. The biggest rally since 1933 helped push the gauge up the requisite 20% from the low it hit Monday, meeting one time-honored definition of a bull market.Right now, it’s a milestone only a statistician could love given the index remains almost 25% below the record high it touched on Feb. 12 -- though that doesn’t mean it won’t keep going.While weird, bounces of similar velocity happen from time to time in fast-moving markets and aren’t taken seriously by market historians until they start to show staying power. U.S. stocks justed ended one of the longest bull markets ever.Other measures of stocks are nowhere near the 20% threshold, with the S&P 500 up...

Co-Diagnostics’ COVID-19 Test Passes Clinical Evaluation; 5-Star Analyst Says ‘Buy’

It might be churlish to suggest there are winners in times of a global pandemic, but it is an unavoidable fact that some companies have benefited from the outbreak. Companies searching for vaccines and those selling hand sanitizer, along with companies with less pertinent issues on their hands, but which fulfill current public stay at home needs are among those to have gained. But none more so than Co-Diagnostics (CODX), a micro-cap healthcare company that has developed a test for the diagnosis of coronavirus. As companies’ valuations have tumbled mercilessly since the outbreak began, CODX shares have soared in the opposite direction. The stock is up by an incredible 919% year-to-date. On March 20, the company announced that, as required for FDA Emergency Use Authorization (EUA), its Logix Smart COVID-19 test had successfully completed its clinical evaluation. The test exhibited 100% sensitivity along with 100% specificity in detecting SARS-CoV-2 (COVID-19), and...